华东医药:2024年第一季度报告(英文版)

Security code: 000963 Stock abbreviation: Huadong Medicine Announcement No.: 2024-041
HuadongMedicineCo.,Ltd.
FirstQuarterlyReport2024
TheCompanyandall membersof the Boardof Directorsherebyguaranteethat the information presented
in this reportis authentic,accurateandcompleteand free of anyfalse records,misleading statementsormaterial
omissions.
Important Declaration:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management of Huadong
Medicine Co., Ltd. (hereinafter referred to as the "Company") hereby guarantee that the information presented
in this report is authentic, accurate and complete and free of false records, misleading statements or material
omissions, andshall undertakeindividual and joint legal liabilities.
2. The Company's legal representative, the officer in charge of accounting, and the head of accounting
department (accounting supervisor) hereby declare that the financial information in this quarterly report is
authentic,accurateandcomplete.
3.Has the First Quarterly Reportbeenaudited
□Yes No
According to “Stock Listing Rules of the Shenzhen Stock Exchange”, if listed companies have both Chinese
and other language version of public notice, they should ensure the content of both versions are the same. In the
caseof discrepancy,theoriginal version in Chinese shall prevail.
I. Key Financial Data
(I) Keyaccountingdataandfinancialindicators
Does the Company need to retroactively adjust or restate the accounting data of previous years
□Yes No
Increase or decrease during the
Current reporting period Same period last year current reporting period compared
with the same period of last year(%)
Operating revenue (RMB) 10,410,809,128.72 10,114,531,331.77 2.93%
Netprofit attributable to
shareholders of the listed 862,411,560.96 755,284,976.47 14.18%
company (RMB)
Netprofit attributable to
shareholders of the listed
company afterdeduction of 838,303,551.41 757,542,618.01 10.66%
non-recurring profits and
losses (RMB)
Netcash flow from operating -484,522,666.13 -246,152,770.16 -96.84%
activities (RMB)
Basic earnings per share 0.4929 0.4316 14.20%
(RMB/share)
Diluted earnings per share 0.4928 0.4315 14.21%
(RMB/share)
Weighted average return on 4.01% 3.99% 0.02%
equity
End of the current Increase or decrease atthe end of the
reporting period End of the last year current reporting period compared
with the end of the last year (%)
Total assets (RMB) 34,467,844,280.37 33,509,361,816.98 2.86%
Owners' equity attributable to
shareholders of listed 21,955,243,888.90 21,047,609,756.66 4.31%
companies (RMB)
(II) Non-recurringprofitandlossitemsandamounts
Applicable □Not applicable
Unit: RMB
Item Amount during the current reporting period Description
Profit and loss on disposal of non-current assets (including 1,521,275.31
the write-off of provision for impairment of assets)
Government grants included in the current profits and
losses (exceptthose that are closely related to the normal
business operation of the Company, comply with national 28,822,099.15
policies and regulations, are enjoyed in accordance with the
defined criteria, and have a lasting impact on the
Company's profits and losses)
Profits and losses from changes in fair value arising from
financial assets and financial liabilities held by non-
financial corporations, and profits and losses from the -25,364.49
disposal of financial assets and liabilities, except for the
effective hedging business related to the normal business
operation of the Company

Other non-operating revenue and expenses other than those -1,436,525.67
mentioned above
Minus: Amount affectedby income tax 4,281